Cited by 241Advanced Drug Delivery SystemsNanoparticle-Based Drug DeliveryDrug Solubulity and Delivery Systems

The DOI matches its Crossref record.

PEGylated Protein Drugs: Basic Science and Clinical Applications

Francesco Maria Veronese·2009·Birkhäuser Basel eBooks

Open this paper in CoChat — free account

Abstract

PEGylation technology and key applications are introduced by this topical volume. Basic physical and chemical properties of PEG as basis for altering/improving in vivo behaviour of PEG-conjugates such

Integrity signals

Registry

Crossref · 10.1007/978-3-7643-8679-5

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Still being checked.

Sorted by citations

PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs
Turecek, P. L., Bossard, M. J., Schoetens, F., & Ivens, I. A. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.015 · Cited by 733
State of the art in PEGylation: The great versatility achieved after forty years of research
Pasut, G., & Veronese, F. M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.037 · Cited by 737
Self-citation
Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval.
Hwang, D., Ramsey, J. D., & Kabanov, A. V. (2020) · Advanced drug delivery reviews · doi:10.1016/j.addr.2020.09.009 · Cited by 699
Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals
Kozma, G. T., Shimizu, T., Ishida, T., & Szebeni, J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.024 · Cited by 696
Polymer therapeutics-prospects for 21st century: The end of the beginning
Duncan, R., & Vicent, M. J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.012 · Cited by 411
Delivery strategies for sustained drug release in the lungs
Loira-Pastoriza, C., Todoroff, J., & Rita Vanbever, A. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.017 · Cited by 395
Polymer–drug conjugates: Origins, progress to date and future directions
Kopec̆ek, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.014 · Cited by 352
Green and Bio-Based Solvents
Calvo‐Flores, F. G., Monteagudo-Arrebola, M. J., Dobado, J. A., & Isac‐García, J. (2018) · Topics in Current Chemistry · doi:10.1007/s41061-018-0191-6 · Cited by 358
Surface Engineering of Liposomes for Stealth Behavior
Nag, O. K., & Awasthi, V. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics5040542 · Cited by 322
Ph-responsive polymer–drug conjugates: design and progress
Pang, X., Jiang, Y., Xiao, Q., Leung, A. W., Hua, H., & Xu, C. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.024 · Cited by 317
Administration, distribution, metabolism and elimination of polymer therapeutics
Markovsky, E., Baabur‐Cohen, H., Eldar‐Boock, A., Omer, L., Tiram, G., Ferber, S., Ofek, P., Polyak, D., Scomparin, A., & Satchi‐Fainaro, R. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.021 · Cited by 315
The enhanced permeability retention effect: a new paradigm for drug targeting in infection
Azzopardi, E., Ferguson, E. L., & Thomas, D. W. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks379 · Cited by 317
Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics
Verhoef, J. J. F., Carpenter, J. F., Anchordoquy, T. J., & Schellekens, H. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.08.015 · Cited by 267
Polymer therapeutics as nanomedicines: new perspectives
Duncan, R. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.05.507 · Cited by 252
Polysarcosine-containing copolymers: synthesis, characterization, self-assembly, and applications
Birke, A., Ling, J., & Barz, M. (2018) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2018.01.002 · Cited by 229
In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines
Doak, S. H., Manshian, B. B., Jenkins, G. J. S., & Singh, N. (2011) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2011.09.013 · Cited by 234
Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications
Jeong, M., Lee, Y., Park, J., Jung, H., & Lee, H. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114990 · Cited by 232
Poly(2-oxazoline)s as materials for biomedical applications
de la Rosa, V. R. (2013) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-013-5034-y · Cited by 220
The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes
Kierstead, P. H., Okochi, H., Venditto, V. J., Chuong, T. C., Kivimae, S., Fréchet, J. M. J., & Szoka, F. C. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.023 · Cited by 210
Process for protein PEGylation
Pfister, D., & Morbidelli, M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.02.002 · Cited by 207
Are Natural Compounds a Promising Alternative to Synthetic Cross-Linking Agents in the Preparation of Hydrogels?
Sapuła, P., Bialik-Wąs, K., & Malarz, K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010253 · Cited by 218
Self-assembly of bioactive peptides, peptide conjugates, and peptide mimetic materials
Edwards‐Gayle, C. J. C., & Hamley, I. W. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob01092c · Cited by 201
Enhancing the pharmacokinetic properties of recombinant factor VIII: first-in-human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A
Tiede, A., Brand, B., Fischer, R. J., Kavaklı, K., Lentz, S. R., Matsushita, T., Rea, C. J., Knobe, K. E., & Viuff, D. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12161 · Cited by 171
Pharmacokinetics, metabolism and distribution of PEGs and PEGylated proteins: quo vadis?
Baumann, A., Tuerck, D., Prabhu, S., Dickmann, L. J., & Sims, J. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.06.002 · Cited by 163
Amphiphilic poly(l-amino acids) — New materials for drug delivery
Lalatsa, A., Schätzlein, A. G., Mazza, M., Le, T. B. H., & Uchegbu, I. F. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.046 · Cited by 163
Pharmacokinetics, pharmacodynamics and safety of aptamers
Kovacevic, K. D., Gilbert, J. C., & Jilma, B. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.008 · Cited by 175
Bioresorbable, Wireless, Passive Sensors as Temporary Implants for Monitoring Regional Body Temperature
Lu, D., Yan, Y., Avila, R. O., Kandela, I. K., Stepien, I., Seo, M., Bai, W., Yang, Q., Li, C., Haney, C. R., et al. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000942 · Cited by 154
Anti-PEG IgE in anaphylaxis associated with polyethylene glycol
Zhou, Z., Stone, C. A., Jakubovic, B. D., Phillips, E. J., Sussman, G., Park, J., Hoang, U., Kirshner, S., Levin, R. L., & Kozlowski, S. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.11.011 · Cited by 134
Effects of pharmaceutical PEGylation on drug metabolism and its clinical concerns
Zhang, X., Wang, H., Ma, Z., & Wu, B. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.967679 · Cited by 117
POxylation as an alternative stealth coating for biomedical applications
Bludau, H., Czapar, A. E., Pitek, A. S., Shukla, S., Jordan, R., & Steinmetz, N. F. (2017) · European Polymer Journal · doi:10.1016/j.eurpolymj.2016.10.041 · Cited by 112
Selectivity of binding of PEGs and PEG-like oligomers to anti-PEG antibodies induced by methoxyPEG-proteins
Saifer, M. G. P., Williams, L. D., Sobczyk, M. A., Michaels, S. J., & Sherman, M. R. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.07.014 · Cited by 112
Sub-lethal toxicity of chlorpyrifos alone and in combination with polyethylene glycol to common carp (Cyprinus carpio)
Hatami, M., Banaee, M., & Haghi, B. N. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.12.077 · Cited by 105
Chemoenzymatic Reversible Immobilization and Labeling of Proteins without Prior Purification
Rashidian, M., Song, J. M., Pricer, R. E., & Distefano, M. D. (2012) · Journal of the American Chemical Society · doi:10.1021/ja211308s · Cited by 100
Targeting Peptides: The New Generation of Targeted Drug Delivery Systems
Todaro, B., Ottalagana, E., Luin, S., & Santi, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061648 · Cited by 107
Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEG
McSweeney, M. D., Price, L., Wessler, T., Ciociola, E. C., Herity, L. B., Piscitelli, J. A., DeWalle, A. C., Harris, T. N., Chan, A. K. P., Saw, R. S., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.08.017 · Cited by 99
Hydroxyethyl starch stabilized polydopamine nanoparticles for cancer chemotherapy
Wu, H., Hu, H., Wan, J., Li, Y., Wu, Y., Tang, Y., Xiao, C., Xu, H., Yang, X., & Li, Z. (2018) · Chemical Engineering Journal · doi:10.1016/j.cej.2018.05.082 · Cited by 98
From design to the clinic: practical guidelines for translating cardiovascular nanomedicine
Cicha, I., Chauvierre, C., Texier, I., Cabella, C., Metselaar, J. M., Szebeni, J., Dézsi, L., Alexiou, C., Rouzet, F., Storm, G., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy219 · Cited by 97
Low-energy-consumption electrochemical CO2 capture driven by biomimetic phenazine derivatives redox medium
Xie, H., Wu, Y., Liu, T., Wang, F., Chen, B., & Liang, B. (2019) · Applied Energy · doi:10.1016/j.apenergy.2019.114119 · Cited by 94
Oral inhalation for delivery of proteins and peptides to the lungs
Fröhlich, E., & Salar-Behzadi, S. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.04.003 · Cited by 92
Fast separation of large biomolecules using short monolithic columns
Podgornik, A., Yamamoto, S., Peterka, M., & Krajnc, N. L. (2013) · Journal of Chromatography B · doi:10.1016/j.jchromb.2013.02.004 · Cited by 95
Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice
Emam, S. E., Elsadek, N. E., Lila, A. S. A., Takata, H., Kawaguchi, Y., Shimizu, T., Ando, H., Ishima, Y., & Ishida, T. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.05.001 · Cited by 91
A minimal physiologically based pharmacokinetic model that predicts anti-PEG IgG-mediated clearance of PEGylated drugs in human and mouse
McSweeney, M. D., Wessler, T., Price, L., Ciociola, E. C., Herity, L. B., Piscitelli, J. A., Zamboni, W. C., Forest, M. G., Cao, Y., & Lai, S. K. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.06.002 · Cited by 86
Hematopoietic Stem and Progenitor Cell Mobilization in Mice and Humans by a First-in-Class Mirror-Image Oligonucleotide Inhibitor of CXCL12
Vater, A., Sahlmann, J., Kröger, N., Zöllner, S. K., Lioznov, M. V., Maasch, C., Buchner, K., Vossmeyer, D., Schwoebel, F., Purschke, W. G., et al. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.58 · Cited by 84
Aqueous phase polymeric corrosion inhibitors: Recent advancements and future opportunities
Verma, C., Quraishi, M. A., & Rhee, K. Y. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.118387 · Cited by 81
Macromolecular therapeutics
Yang, J., & Kopec̆ek, J. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.013 · Cited by 78
Chemical Approaches to Synthetic Drug Delivery Systems for Systemic Applications
Braatz, D., Cherri, M., Tully, M., Dimde, M., Ma, G., Mohammadifar, E., Reisbeck, F., Ahmadi, V., Schirner, M., & Haag, R. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202203942 · Cited by 78
Recommendations for the characterization of immunogenicity response to multiple domain biotherapeutics
Gorovits, B., Wakshull, E., Pillutla, R. C., Xu, Y., Manning, M. S., & Goyal, J. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.05.010 · Cited by 78
Protein HESylation for half-life extension: Synthesis, characterization and pharmacokinetics of HESylated anakinra
Liebner, R., Mathaes, R., Meyer, M., Hey, T., Winter, G., & Besheer, A. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.03.010 · Cited by 75
Design Rationale and Development Approach for Pegfilgrastim as a Long-Acting Granulocyte Colony-Stimulating Factor
Arvedson, T., O’Kelly, J., & Yang, B. (2015) · BioDrugs · doi:10.1007/s40259-015-0127-4 · Cited by 74
Protein Engineering Strategies for Improved Pharmacokinetics
Rondon, A., Mahri, S., Morales-Yánez, F., Dumoulin, M., & Rita Vanbever, A. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202101633 · Cited by 73
Polysarcosine brush stabilized gold nanorods for in vivo near-infrared photothermal tumor therapy
Zhu, H., Chen, Y., Yan, F., Chen, J., Tao, X., Ling, J., Yang, B., He, Q., & Mao, Z. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.12.050 · Cited by 70
Pharmacokinetic, Biodistribution, and Biophysical Profiles of TNF Nanobodies Conjugated to Linear or Branched Poly(ethylene glycol)
Vugmeyster, Y., Entrican, C., Joyce, A. P., Lawrence-Henderson, R. F., Leary, B. A., Mahoney, C. S., Patel, H. K., Raso, S. W., Olland, S., Hegen, M., et al. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300066a · Cited by 67
Comparative Binding of Disulfide-Bridged PEG-Fabs
Khalili, H., Godwin, A., Choi, J.-W., Lever, R., & Brocchini, S. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300372r · Cited by 66
TGFβ functionalized starPEG-heparin hydrogels modulate human dermal fibroblast growth and differentiation
Watarai, A., Schirmer, L., Thönes, S., Freudenberg, U., Werner, C., Simon, J. C., & Anderegg, U. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.07.036 · Cited by 71
Emerging Challenges and Innovations in Surfactant-mediated Stabilization of Biologic Formulations
Katz, J. S., Chou, D. K., Christian, T. R., Das, T. K., Patel, M., Singh, S. N., & Wen, Y. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.12.002 · Cited by 64
Luminescent quantum-dot-sized conjugated polymernanoparticles—nanoparticle formation in a miniemulsion system
Hashim, Z., Howes, P. D., & Green, M. (2010) · Journal of Materials Chemistry · doi:10.1039/c0jm02935a · Cited by 62
Criteria for Selecting PEGylation Sites on Proteins for Higher Thermodynamic and Proteolytic Stability
Lawrence, P. B., Gavrilov, Y., Matthews, S. S., Langlois, M. I., Shental-Bechor, D., Greenblatt, H. M., Pandey, B. K., Smith, M. S., Paxman, R. J., Torgerson, C. D., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5095183 · Cited by 62
Polymer-drug conjugates: recent progress on administration routes
Pang, X., Yang, X., & Zhai, G. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.912779 · Cited by 55
PEGylation: Posttranslational bioengineering of protein biotherapeutics
Veronese, F. M., & Pasut, G. (2008) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2009.02.002 · Cited by 54
Self-citation
Neutron reflectometry from poly (ethylene-glycol) brushes binding anti-PEG antibodies: Evidence of ternary adsorption
Schneck, E., Berts, I., Halperin, A., Daillant, J., & Fragneto, G. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.12.041 · Cited by 54
Treatment-induced and Pre-existing Anti-peg Antibodies: Prevalence, Clinical Implications, and Future Perspectives
Gaballa, S. A., Shimizu, T., Ando, H., Takata, H., Emam, S. E., Ramadan, E., Naguib, Y. W., Mady, F. M., Khaled, K. A., & Ishida, T. (2023) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2023.11.001 · Cited by 60
Enabling sublingual peptide immunization with molecular self-assemblies
Kelly, S. H., Wu, Y., Varadhan, A. K., Curvino, E. J., Chong, A. S., & Collier, J. H. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119903 · Cited by 53
Emerging well-tailored nanoparticulate delivery system based on in situ regulation of the protein corona
Li, Z., Wang, Y., Zhu, J., Zhang, Y., Zhang, W., Zhou, M., Luo, C., Li, Z. J., Cai, B., Gui, S., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.007 · Cited by 50
Polymeric Nanomaterials
Raja, M. M., Lim, P. Q., Wong, Y. S., Xiong, G. M., Zhang, Y., Venkatraman, S. S., & Huang, Y. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814033-8.00018-7 · Cited by 51
Isoform separation and binding site determination of mono-PEGylated lysozyme with pH gradient chromatography
Maiser, B., Kröner, F., Dismer, F., Brenner‐Weiß, G., & Hubbuch, J. J. (2012) · Journal of Chromatography A · doi:10.1016/j.chroma.2012.10.047 · Cited by 49
The Impact of Product and Process Related Critical Quality Attributes on Immunogenicity and Adverse Immunological Effects of Biotherapeutics
Wen, Y., & Jawa, V. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.12.003 · Cited by 51
Aldehyde PEGylation Kinetics: A Standard Protein versus a Pharmaceutically Relevant Single Chain Variable Fragment
Moosmann, A., Blath, J., Lindner, R. M., Müller, E., & Böttinger, H. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200090x · Cited by 46
PEG‐Like Brush Polymer Conjugate of RNA Aptamer That Shows Reversible Anticoagulant Activity and Minimal Immune Response
Özer, İ., Pitoc, G. A., Layzer, J. M., Moreno, A., Olson, L. B., Layzer, K. D., Hucknall, A., Sullenger, B. A., & Chilkoti, A. (2022) · Advanced Materials · doi:10.1002/adma.202107852 · Cited by 46
Site-Specific PEGylation of Therapeutic Proteins via Optimization of Both Accessible Reactive Amino Acid Residues and PEG Derivatives
Zhang, C., Yang, X., Yuan, Y., Pu, J., & Liao, F. (2012) · BioDrugs · doi:10.1007/bf03261880 · Cited by 46
Characterization of protein release from poly(ethylene glycol) hydrogels with crosslink density gradients
Bal, T., Kepsutlu, B., & Kızılel, S. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34701 · Cited by 44
Dynamic Covalent Bond‐Assisted Programmed and Traceless Protein Release: High Loading Nanogel for Systemic and Cytosolic Delivery
Su, S., Wang, Y., Du, F., Lu, H., & Li, Z. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201805287 · Cited by 44
Polyethylene glycol: Properties, applications, and challenges
Gaballa, S. A., Naguib, Y. W., Mady, F. M., & Khaled, K. (2023) · Journal of advanced Biomedical and Pharmaceutical Sciences · doi:10.21608/jabps.2023.241685.1205 · Cited by 52
Cleaner approach for improving the papermaking from agro and hardwood blended pulps using biopolymers
Bhardwaj, S., Bhardwaj, N. K., & Negi, Y. S. (2018) · Journal of Cleaner Production · doi:10.1016/j.jclepro.2018.12.143 · Cited by 43
Hydrophobic interaction chromatography for purification of monoPEGylated RNase A
Mayolo‐Deloisa, K., Lienqueo, M. E., Andrews, B. A., Rito‐Palomares, M., & Asenjo, J. A. (2012) · Journal of Chromatography A · doi:10.1016/j.chroma.2012.03.079 · Cited by 42
Advances and trends in the design, analysis, and characterization of polymer–protein conjugates for “PEGylaided” bioprocesses
González‐Valdez, J., Rito‐Palomares, M., & Benavides, J. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-5845-6 · Cited by 42
Flow cytometry analysis of anti-polyethylene glycol antibodies in human plasma
Fang, J., Beland, F. A., Tang, Y., & Roffler, S. R. (2020) · Toxicology Reports · doi:10.1016/j.toxrep.2020.12.022 · Cited by 43
PEGylated Human Serum Albumin: Review of PEGylation, Purification and Characterization Methods
Akbarzadehlaleh, P., Mirzaei, M., Mashahdi-keshtiban, M., Shamsasenjan, K., & Heidari, H. R. (2016) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2016.043 · Cited by 41
Accelerated clearance by antibodies against methoxy PEG depends on pegylation architecture
Lin, Y., Chen, B., Tran, T. T. M., Chang, T.-C., Al‐Qaisi, T. S., & Roffler, S. R. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.021 · Cited by 40
PEGylation and pharmacological characterization of a potential anti-tumor drug, an engineered arginine deiminase originated from Pseudomonas plecoglossicida
Zhang, L., Liu, M., Jamil, S., Han, R., Xu, G., & Ni, Y. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.042 · Cited by 40
Purification of PEGylated Proteins
Fee, C. J., & Alstine, J. M. V. (2011) · Methods of biochemical analysis · doi:10.1002/9780470939932.ch14 · Cited by 40
Gold nanostructures in melanoma: Advances in treatment, diagnosis, and theranostic applications
Dastgheib, Z. S., Abolmaali, S. S., Farahavar, G., Salmanpour, M., & Tamaddon, A. M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35655 · Cited by 44
Poly(ethylene glycol)-Radix Ophiopogonis polysaccharide conjugates: Preparation, characterization, pharmacokinetics and in vitro bioactivity
Lin, X., Wang, S., Jiang, Y., Wang, Z.-J., Sun, G., De-sheng, X., Feng, Y., & Shen, L. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.07.003 · Cited by 38
P(HPMA)-block-P(LA) copolymers in paclitaxel formulations: Polylactide stereochemistry controls micellization, cellular uptake kinetics, intracellular localization and drug efficiency
Barz, M., Armiñán, A., Canal, F., Wolf, F. K., Koynov, K., Frey, H., Zentel, R., & Vicent, M. J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.024 · Cited by 39
Pushing the science forward: chitosan nanoparticles and functional repair of CNS tissue after spinal cord injury
Chen, B., Bohnert, D. M., Borgens, R. B., & Cho, Y. (2013) · Journal of Biological Engineering · doi:10.1186/1754-1611-7-15 · Cited by 36
Oligo(ethylene glycol)-sidechain microgels prepared in absence of cross-linking agent: Polymerization, characterization and variation of particle deformability
Welsch, N., & Lyon, L. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181369 · Cited by 35
Polyvinyl Alcohol as a Biocompatible Alternative for the Passivation of Gold Nanorods
Kinnear, C., Burnand, D., Clift, M. J. D., Kilbinger, A. F. M., Rothen‐Rutishauser, B., & Petri‐Fink, A. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201404100 · Cited by 35
Head to Head Comparison of the Formulation and Stability of Concentrated Solutions of HESylated versus PEGylated Anakinra
Liebner, R., Meyer, M., Hey, T., Winter, G., & Besheer, A. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24253 · Cited by 33
Pharmacokinetics, excretion, distribution, and metabolism of 60-kDa polyethylene glycol used in BAY 94-9027 in rats and its value for human prediction
Baumann, A., Piel, I., Hucke, F., Sandmann, S., Hetzel, T., & Schwarz, T. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.01.015 · Cited by 33
Near-infrared activatable phthalocyanine-poly-L-glutamic acid conjugate: increased cellular uptake and light–dark toxicity ratio toward an effective photodynamic cancer therapy
Kiew, L. V., Cheah, H. Y., Voon, S. H., Gallon, E., Movellan, J., Ng, K. H., Alpugan, S., Lee, H. B., Dumoulin, F., Vicent, M. J., et al. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.02.002 · Cited by 32
Pharmacokinetics, tissue distribution and excretion of 40kDa PEG and PEGylated rFVIII (N8-GP) in rats
Bjørnsdottir, I., Sternebring, O., Kappers, W. A., Selvig, H., Kornø, H. T., Kristensen, J. B., & Bagger, M. A. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.10.020 · Cited by 31
Effect of spatial distribution of wax and PEG-isocyanate on the morphology and hydrophobicity of starch films
Muscat, D., Adhikari, R., Tobin, M. J., McKnight, S. W., Wakeling, L., & Adhikari, B. (2014) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.04.072 · Cited by 30
Liposomes Modified with Superhydrophilic Polymer Linked to a Nonphospholipid Anchor Exhibit Reduced Complement Activation and Enhanced Circulation
Nag, O. K., Yadav, V. R., Croft, B., Hedrick, A. F., & Awasthi, V. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24254 · Cited by 30
Polyethylene glycols and polysorbates: Two still neglected ingredients causing true IgE-mediated reactions
Calogiuri, G., Foti, C., Nettis, E., Leo, E. D., Macchia, L., & Vacca, A. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.05.058 · Cited by 29
Effect of PEGylation on assembly morphology and cellular uptake of poly ethyleneimine-cholesterol conjugates for delivery of sorafenib tosylate in hepatocellular carcinoma
Monajati, M., Tavakoli, S., Yousefi, G. H., Abolmaali, S. S., & Tamaddon, A. M. (2018) · Bioimpacts · doi:10.15171/bi.2018.27 · Cited by 29
Metabolism of bioconjugate therapeutics: why, when, and how?
Liu, H., Bolleddula, J., Nichols, A. J., Tang, L., Zhao, Z., & Prakash, C. (2020) · Drug Metabolism Reviews · doi:10.1080/03602532.2020.1716784 · Cited by 29
On-Demand and Tunable Dual Wavelength Release of Antibodies Using Light-Responsive Hydrogels
LeValley, P. J., Sutherland, B. P., Jaje, J., Gibbs, S. K., Jones, R. M., Gala, R. P., Kloxin, C. J., Kiick, K. L., & Kloxin, A. M. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00823 · Cited by 29
Preparation and Characterization of PEGylated Amylin
Guerreiro, L. H., Guterres, M. F. A. N., Melo-Ferreira, B., Erthal, L. C. S., Rosa, M. D. S., Lourenço, D. C., Tinoco, P., & Lima, L. M. T. R. (2013) · AAPS PharmSciTech · doi:10.1208/s12249-013-9987-4 · Cited by 28
Tunable, bioactive protein conjugated hyaluronic acid hydrogel for neural engineering applications
Shendi, D., Dede, A., Yin, Y., Wang, C., Valmikinathan, C. M., & Jain, A. (2016) · Journal of Materials Chemistry B · doi:10.1039/c5tb02235e · Cited by 28
The Application of Nanotechnology to Drug Delivery in Medicine
McDonald, T. O., Siccardi, M., Moss, D. M., Liptrott, N. J., Giardiello, M., Rannard, S. P., & Owen, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-62747-6.00007-5 · Cited by 26
Polyacetal-stilbene conjugates — The first examples of polymer therapeutics for the inhibition of HIF-1 in the treatment of solid tumours
England, R., Masiá, E., Giménez, V., Lucas-Domínguez, R., & Vicent, M. J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.08.017 · Cited by 26

Authors: Veronese, F. M.
Affiliations: University of Padua (IT)
Corresponding author: Francesco Maria Veronese
ORCID: Francesco Maria Veronese
Venue: Birkhäuser Basel eBooks
Publisher: Birkhäuser Basel
Published: 2009
DOI: 10.1007/978-3-7643-8679-5
OpenAlex: W618357767
Cited by: 241
References: 0
Citations by year: 2025: 8 · 2024: 7 · 2023: 14 · 2022: 13 · 2021: 19 · 2020: 19 · 2019: 16 · 2018: 17 · 2017: 13 · 2016: 15 · 2015: 16 · 2014: 23 · 2013: 22 · 2012: 21
FWCI: 2.22
Type: book
Language: en
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Birkhäuser Basel eBooks (publishedVersion)
DIAL (Catholic University of Leuven) (submittedVersion)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
Keywords: PEGylation, polyethylene glycol, PEG conjugates, protein drugs, drug modification, pharmacokinetics, drug delivery, clinical application

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

PEGylated Protein Drugs: Basic Science and Clinical Applications

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks